Evidence map›Paper›PMID 26973654›Full record

ArticleFrontiers in immunology2016

Structural and Functional Characterization of a Single-Chain Form of the Recognition Domain of Complement Protein C1q.

Christophe Moreau, Isabelle Bally, Anne Chouquet, Barbara Bottazzi, Berhane Ghebrehiwet, Christine Gaboriaud, Nicole Thielens

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. C1q: A fresh look upon an old molecule.Molecular immunology · 2017
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Christophe MoreauIBS, University of Grenoble Alpes, Grenoble, France; CNRS, IBS, Grenoble, France; IBS, CEA, Grenoble, France.
Isabelle BallyIBS, University of Grenoble Alpes, Grenoble, France; CNRS, IBS, Grenoble, France; IBS, CEA, Grenoble, France.
Anne ChouquetIBS, University of Grenoble Alpes, Grenoble, France; CNRS, IBS, Grenoble, France; IBS, CEA, Grenoble, France.
Barbara BottazziImmunopharmacology Laboratory, Humanitas Research Hospital , Rozzano , Italy.
Berhane GhebrehiwetDepartment of Medicine, Stony Brook University , Stony Brook, NY , USA.
Christine GaboriaudIBS, University of Grenoble Alpes, Grenoble, France; CNRS, IBS, Grenoble, France; IBS, CEA, Grenoble, France.
Nicole ThielensIBS, University of Grenoble Alpes, Grenoble, France; CNRS, IBS, Grenoble, France; IBS, CEA, Grenoble, France.
Institut de Biologie Structurale · FRCEA Grenoble · FRIRCCS Humanitas Research Hospital · ITStony Brook University · USUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complement C1q is a soluble pattern recognition molecule comprising six heterotrimeric subunits assembled from three polypeptide chains (A-C). Each heterotrimer forms a collagen-like stem prolonged by a globular recognition domain. These recognition domains sense a wide variety of ligands, including pathogens and altered-self components. Ligand recognition is either direct or mediated by immunoglobulins or pentraxins. Multivalent binding of C1q to its targets triggers immune effector mechanisms mediated via its collagen-like stems. The induced immune response includes activation of the classical complement pathway and enhancement of the phagocytosis of the recognized target. We report here, the first production of a single-chain recombinant form of human C1q globular region (C1q-scGR). The three monomers have been linked in tandem to generate a single continuous polypeptide, based on a strategy previously used for adiponectin, a protein structurally related to C1q. The resulting C1q-scGR protein was produced at high yield in stably transfected 293-F mammalian cells. Recombinant C1q-scGR was correctly folded, as demonstrated by its X-ray crystal structure solved at a resolution of 1.35 Å. Its interaction properties were assessed by surface plasmon resonance analysis using the following physiological C1q ligands: the receptor for C1q globular heads, the long pentraxin PTX3, calreticulin, and heparin. The 3D structure and the binding properties of C1q-scGR were similar to those of the three-chain fragment generated by collagenase digestion of serum-derived C1q. Comparison of the interaction properties of the fragments with those of native C1q provided insights into the avidity component associated with the hexameric assembly of C1q. The interest of this functional recombinant form of the recognition domains of C1q in basic research and its potential biomedical applications are discussed.

Indexed as

C1qcomplementinnate immune recognitionprotein engineeringsurface plasmon resonanceX-ray crystallography

Identifiers

PMID26973654
PMCPMC4774423
OpenAlexW2297905706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.